According to 4basebio's latest financial reports the company's current EPS (TTM) is C-$1.09. In 2023 the company made an earnings per share (EPS) of C-$1.09 a decrease over its 2022 EPS that were of C-$0.70.
Year | EPS | Change |
---|---|---|
2023 | C-$1.09 | 55.45% |
2022 | C-$0.70 | 44.78% |
2021 | C-$0.48 | 341.1% |
2020 | C-$0.11 | 76.69% |
2019 | C-$0.06200 |